92 related articles for article (PubMed ID: 9289689)
1. [ACE inhibitor therapy of hemodialyzed patients].
Pató E; Radó J
Orv Hetil; 1997 Jul; 138(30):1903-7. PubMed ID: 9289689
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
[TBL] [Abstract][Full Text] [Related]
4. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Vlasses PH; Larijani GE; Conner DP; Ferguson RK
Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
[TBL] [Abstract][Full Text] [Related]
5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
6. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
8. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors].
Alimento M; Campodonico J; Santambrogio G; Rossi M; Trabattoni D; Celeste F; Guazzi M
Cardiologia; 1997 Jun; 42(6):605-10. PubMed ID: 9289376
[TBL] [Abstract][Full Text] [Related]
9. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
10. Clearance of imidapril, an Angiotensin-converting enzyme inhibitor, during hemodialysis in hypertensive renal failure patients: comparison with quinapril and enalapril.
Tsuruoka S; Kitoh Y; Kawaguchi A; Sugimoto K; Hayasaka T; Saito T; Fujimura A
J Clin Pharmacol; 2007 Feb; 47(2):259-63. PubMed ID: 17244777
[TBL] [Abstract][Full Text] [Related]
11. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy for hypertension in hemodialysis patients.
Hörl MP; Tepel M
Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
[TBL] [Abstract][Full Text] [Related]
13. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
Lindsjö M; Danielson BG; Weiss L; Wikström B
Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326
[TBL] [Abstract][Full Text] [Related]
14. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
15. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
17. [The effect of enalapril and captopril on emotional processes in hypertensive patients].
Karwowska-Polecka W; Halicka D; Jakubów P; Braszko JJ
Psychiatr Pol; 2002; 36(4):591-601. PubMed ID: 12298188
[TBL] [Abstract][Full Text] [Related]
18. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
19. Selenium-dependent GSH-Px in erythrocytes of patients with hypertension treated with ACE inhibitors.
Djordjević VB; Grubor-Lajsić G; Jovanovic-Galović A; Pavlović D; Cvetković T; Pejović M; Lecić N
J Environ Pathol Toxicol Oncol; 1998; 17(3-4):277-80. PubMed ID: 9726802
[TBL] [Abstract][Full Text] [Related]
20. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
Bourgault C; Elstein E; Le Lorier J; Suissa S
CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
